Joe Illingworth Email

Director, Research . DJS Antibodies

Current Roles

Employees:
21
Revenue:
$3.3M
About
At DJS we are developing novel therapeutics to treat chronic inflammatory diseases. We do this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. Our breakthrough technology enables us to produce first-in-class antibody therapeutics to previously intractable disease targets.
DJS Antibodies Address
Wood Centre for Innovation
Oxford, null
DJS Antibodies Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.